INTERNATIONAL PATENT: SHANGHAI RENDU BIOTECHNOLOGY CO., LTD., 上海仁度生物科技股份有限公司 FILES APPLICATION FOR "DIGITAL DROPLET RNA AMPLIFICATION DETECTION SYSTEM FOR PROSTATE CANCER AND METHOD FOR REDUCING FALSE NEGATIVE RATE OF PROSTATE CANCER"

Posted On: 2025-12-08

GENEVA, Dec. 8 -- SHANGHAI RENDU BIOTECHNOLOGY CO., LTD. (Building 15B, No. 528 Ruiqing Road, East District, Zhangjiang High Tech ParkPudong New Area, Shanghai 201201), 上海仁度生物科技股份有限公司 (中国上海市浦东新区张江高科技园区东区瑞庆路528号15幢乙号) filed a patent application (PCT/CN2025/097657) for "DIGITAL DROPLET RNA AMPLIFICATION DETECTION SYSTEM FOR PROSTATE CANCER AND METHOD FOR REDUCING FALSE NEGATIVE RATE OF PROSTATE CANCER" on May 28, 2025. With publication no. WO/2025/247251, the details related...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SHANGHAI RENDU BIOTECHNOLOGY CO., LTD., 上海仁度生物科技股份有限公司 FILES APPLICATION FOR "DIGITAL DROPLET RNA AMPLIFICATION DETECTION SYSTEM FOR PROSTATE CANCER AND METHOD FOR REDUCING FALSE NEGATIVE RATE OF PROSTATE CANCER"